{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:31:56Z","timestamp":1790703116424,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Laboratory of Excellence (LabEx) LERMIT","award":["ANR-10-LABX-33"],"award-info":[{"award-number":["ANR-10-LABX-33"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>This study aimed to investigate compounds acting on the host cell machinery to impair parasite installation with the possible advantage of limiting drug resistance. The strategy therefore consisted of selecting compounds that are poorly active on the axenic parasite, but very active on the intramacrophage form of Leishmania.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To identify a drug candidate from focused screening of adamantamine derivatives that can inhibit the development of Leishmania infantum in macrophages.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In vitro screening was performed on a library of 142 adamantamine derivatives with axenic and intramacrophage forms of L. infantum, as well as cytotoxicity assays, allowing selection of the most promising compound. Absorption, distribution, metabolism and excretion (ADME) experiments, including pharmacokinetics and microsomal stability, were performed and finally the physicochemical stability of the compound was investigated to assess its suitability for further drug development.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>VP343 was identified first in vitro, with a CC50 value of 63.7\u2009\u03bcM and an IC50 value of 0.32\u2009\u03bcM for L. infantum intramacrophage amastigotes and then in vivo, with a 59% reduction of the liver parasite burden after oral administration at 10\u2009mg\/kg\/day for 5\u2009days. In addition, the ADME data were compatible with moving this compound further through the antileishmanial drug candidate pipeline.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>VP343 has the properties of a good drug candidate and merits further investigations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkab226","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T11:07:32Z","timestamp":1623755252000},"page":"2640-2650","source":"Crossref","is-referenced-by-count":16,"title":["An adamantamine derivative as a drug candidate for the treatment of visceral leishmaniasis"],"prefix":"10.1093","volume":"76","author":[{"given":"S\u00e9bastien","family":"Pomel","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, CNRS, BioCIS, 92290, Ch\u00e2tenay-Malabry, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Cojean","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, CNRS, BioCIS, 92290, Ch\u00e2tenay-Malabry, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Pons","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, CEA, INRAE, D\u00e9partement M\u00e9dicaments et Technologies pour la Sant\u00e9 (DMTS), SCBM, 91191, Gif-sur-Yvette, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Cintrat","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, CEA, INRAE, D\u00e9partement M\u00e9dicaments et Technologies pour la Sant\u00e9 (DMTS), SCBM, 91191, Gif-sur-Yvette, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, CEA, INRAE, D\u00e9partement M\u00e9dicaments et Technologies pour la Sant\u00e9 (DMTS), SPI, 91191, Gif-sur-Yvette, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Vacus","sequence":"additional","affiliation":[{"name":"Drugabilis, 7, All\u00e9e de Londres, 91140, Villejust, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Pruvost","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, CEA, INRAE, D\u00e9partement M\u00e9dicaments et Technologies pour la Sant\u00e9 (DMTS), SPI, 91191, Gif-sur-Yvette, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2187-4973","authenticated-orcid":false,"given":"Julien","family":"Barbier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, CEA, INRAE, D\u00e9partement M\u00e9dicaments et Technologies pour la Sant\u00e9 (DMTS), SIMoS, 91191, Gif-sur-Yvette, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0477-3599","authenticated-orcid":false,"given":"Daniel","family":"Gillet","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, CEA, INRAE, D\u00e9partement M\u00e9dicaments et Technologies pour la Sant\u00e9 (DMTS), SIMoS, 91191, Gif-sur-Yvette, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe M","family":"Loiseau","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, CNRS, BioCIS, 92290, Ch\u00e2tenay-Malabry, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"2021091708523249000_dkab226-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12639-020-01212-w","article-title":"Leishmaniasis diagnosis: an update on the use of parasitological, immunological and molecular methods","volume":"44","author":"Thakur","year":"2020","journal-title":"J Parasit Dis"},{"key":"2021091708523249000_dkab226-B2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1471-4922(02)02347-4","article-title":"Canine leishmaniasis: epidemiological risk and the experimental model","volume":"18","author":"Moreno","year":"2002","journal-title":"Trends Parasitol"},{"key":"2021091708523249000_dkab226-B3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.vetpar.2018.03.002","article-title":"Clinical management of canine leishmaniosis versus human leishmaniasis due to Leishmania infantum: putting \u201cOne Health\u201d principles into practice","volume":"254","author":"Mir\u00f3","year":"2018","journal-title":"Vet Parasitol"},{"key":"2021091708523249000_dkab226-B4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13071-019-3323-0","article-title":"Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil","volume":"12","author":"Dos Santos Nogueira","year":"2019","journal-title":"Parasit Vectors"},{"key":"2021091708523249000_dkab226-B5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3201\/eid1407.071589","article-title":"Spread of vector-borne diseases and neglect of leishmaniasis, Europe","volume":"14","author":"Dujardin","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"2021091708523249000_dkab226-B6","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","article-title":"Recent advances and new strategies on leishmaniasis treatment","volume":"104","author":"Mendes Roatt","year":"2020","journal-title":"Appl Microbiol Biotechnol"},{"key":"2021091708523249000_dkab226-B7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3201\/eid1804.110841","article-title":"Leishmania resistance to miltefosine associated with genetic marker","volume":"18","author":"Cojean","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"2021091708523249000_dkab226-B8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/tmi.13382","article-title":"Commercially approved vaccines for canine leishmaniosis: a review of available data on their safety and efficacy","volume":"25","author":"Velez","year":"2020","journal-title":"Trop Med Int Health"},{"key":"2021091708523249000_dkab226-B9","doi-asserted-by":"crossref","first-page":"3967436","DOI":"10.1155\/2016\/3967436","article-title":"Dendritic cells and Leishmania infection: adding layers of complexity to a complex disease","volume":"2016","author":"Feijo","year":"2016","journal-title":"J Immunol Res"},{"key":"2021091708523249000_dkab226-B10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1146\/annurev-micro-090110-102913","article-title":"Metabolic pathways required for the intracellular survival of Leishmania","volume":"65","author":"McConville","year":"2011","journal-title":"Annu Rev Microbiol"},{"key":"2021091708523249000_dkab226-B11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1128\/iai.26.1.375-379.1979","article-title":"Multiplication of Leishmania in human macrophages in vitro","volume":"26","author":"Berman","year":"1979","journal-title":"Infect Immun"},{"key":"2021091708523249000_dkab226-B12","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/iai.32.3.1249-1253.1981","article-title":"Interaction of Leishmania donovani promastigotes with human monocyte-derived macrophages: parasite entry, intracellular survival, and multiplication","volume":"32","author":"Pearson","year":"1981","journal-title":"Infect Immun"},{"key":"2021091708523249000_dkab226-B13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/00034983.1984.11811781","article-title":"In vivo fusion of lysosomes with parasitophorous vacuoles of Leishmania-infected macrophages","volume":"78","author":"Brazil","year":"1984","journal-title":"Ann Trop Med Parasitol"},{"key":"2021091708523249000_dkab226-B14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/iai.59.3.764-775.1991","article-title":"Localization of major histocompatibility complex class II molecules in phagolysosomes of murine macrophages infected with Leishmania amazonensis","volume":"59","author":"Antoine","year":"1991","journal-title":"Infect Immun"},{"key":"2021091708523249000_dkab226-B15","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1645\/GE-841R.1","article-title":"The ultrastructure of the parasitophorous vacuole formed by Leishmania major","volume":"92","author":"Castro","year":"2006","journal-title":"J Parasitol"},{"key":"2021091708523249000_dkab226-B16","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/j.1462-5822.2010.01483.x","article-title":"Leishmania parasitophorous vacuoles interact continuously with the host cell\u2019s endoplasmic reticulum; parasitophorous vacuoles are hybrid compartments","volume":"12","author":"Ndjamen","year":"2010","journal-title":"Cell Microbiol"},{"key":"2021091708523249000_dkab226-B17","doi-asserted-by":"crossref","first-page":"e1518","DOI":"10.1371\/journal.pntd.0001518","article-title":"The diverse and dynamic nature of Leishmania parasitophorous vacuoles studied by multidimensional imaging","volume":"6","author":"Real","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"2021091708523249000_dkab226-B18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/iai.58.3.779-787.1990","article-title":"Parasitophorous vacuoles of Leishmania amazonensis-infected macrophages maintain an acidic pH","volume":"58","author":"Antoine","year":"1990","journal-title":"Infect Immun"},{"key":"2021091708523249000_dkab226-B19","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1128\/iai.58.6.1730-1737.1990","article-title":"Localization and activity of various lysosomal proteases in Leishmania amazonensis-infected macrophages","volume":"58","author":"Prina","year":"1990","journal-title":"Infect Immun"},{"key":"2021091708523249000_dkab226-B20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1242\/jcs.107.1.69","article-title":"Distribution of MHC class I and of MHC class II molecules in macrophages infected with Leishmania amazonensis","volume":"107","author":"Lang","year":"1994","journal-title":"J Cell Sci"},{"key":"2021091708523249000_dkab226-B21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1242\/jcs.112.5.681","article-title":"Parasitophorous vacuoles of Leishmania mexicana acquire macromolecules from the host cell cytosol via two independent routes","volume":"112","author":"Schaible","year":"1999","journal-title":"J Cell Sci"},{"key":"2021091708523249000_dkab226-B22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1462-5822.1999.00002.x","article-title":"Impaired recruitment of the small GTPase rab7 correlates with the inhibition of phagosome maturation by Leishmania donovani promastigotes","volume":"1","author":"Scianimanico","year":"1999","journal-title":"Cell Microbiol"},{"key":"2021091708523249000_dkab226-B23","doi-asserted-by":"crossref","first-page":"e19000","DOI":"10.1371\/journal.pone.0019000","article-title":"Stage-specific pathways of Leishmania infantum chagasi entry and phagosome maturation in macrophages","volume":"6","author":"Rodriguez","year":"2011","journal-title":"PLoS One"},{"key":"2021091708523249000_dkab226-B24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/jac\/dkm219","article-title":"Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes","volume":"60","author":"Miguel","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"2021091708523249000_dkab226-B25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijantimicag.2008.10.013","article-title":"N-(2-hydroxypropyl)methacrylamide-amphotericin B (HPMA-AmB) copolymer conjugates as antileishmanial agents","volume":"33","author":"Nicoletti","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"2021091708523249000_dkab226-B26","doi-asserted-by":"crossref","first-page":"e49496","DOI":"10.1371\/journal.pone.0049496","article-title":"17-AAG kills intracellular Leishmania amazonensis while reducing inflammatory responses in infected macrophages","volume":"7","author":"Petersen","year":"2012","journal-title":"PloS One"},{"key":"2021091708523249000_dkab226-B27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cell.2010.01.043","article-title":"Inhibition of retrograde transport protects mice from lethal ricin challenge","volume":"141","author":"Stechmann","year":"2010","journal-title":"Cell"},{"key":"2021091708523249000_dkab226-B28","doi-asserted-by":"crossref","first-page":"15567","DOI":"10.1038\/s41598-017-15466-7","article-title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"2021091708523249000_dkab226-B29","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.ajpath.2012.06.041","article-title":"Targeting host syntaxin-5 preferentially blocks Leishmania parasitophorous vacuole development in infected cells and limits experimental Leishmania infections","volume":"181","author":"Canton","year":"2012","journal-title":"Am J Pathol"},{"key":"2021091708523249000_dkab226-B30","doi-asserted-by":"crossref","first-page":"e0005556","DOI":"10.1371\/journal.pntd.0005556","article-title":"Structurally optimized analogs of the retrograde trafficking inhibitor Retro-2cycl limit Leishmania infections","volume":"11","author":"Craig","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2021091708523249000_dkab226-B31","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1111\/febs.15201","article-title":"Regulation of endo-lysosomal pathway and autophagic flux by broad-spectrum antipathogen inhibitor ABMA","volume":"287","author":"Wu","year":"2020","journal-title":"FEBS J"},{"key":"2021091708523249000_dkab226-B32","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1021\/acsmedchemlett.9b00155","article-title":"DABMA: a derivative of ABMA with improved broad-spectrum inhibitory activity of toxins and viruses","volume":"10","author":"Wu","year":"2019","journal-title":"ACS Med Chem Lett"},{"key":"2021091708523249000_dkab226-B33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1126\/science.aaa3778","article-title":"Infectious disease. Combating emerging viral threats","volume":"348","author":"Bekerman","year":"2015","journal-title":"Science"},{"key":"2021091708523249000_dkab226-B34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"2021091708523249000_dkab226-B35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41598-017-00848-8","article-title":"Biochemical analysis of leishmanial and human GDP-mannose pyrophosphorylases and selection of inhibitors as new leads","volume":"7","author":"Mao","year":"2017","journal-title":"Sci Rep"},{"key":"2021091708523249000_dkab226-B36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpddr.2018.01.006","article-title":"In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series","volume":"8","author":"Van den Kerkhof","year":"2018","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2021091708523249000_dkab226-B37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3390\/molecules25030465","article-title":"Synthesis and antileishmanial activity of 1,2,4,5-tetraoxanes against Leishmania donovani","volume":"25","author":"Cabral","year":"2020","journal-title":"Molecules"},{"key":"2021091708523249000_dkab226-B38","doi-asserted-by":"crossref","first-page":"e0006052","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/10\/2640\/40394379\/dkab226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/10\/2640\/40394379\/dkab226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T08:57:05Z","timestamp":1631869025000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/76\/10\/2640\/6312942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,7,2]]},"published-print":{"date-parts":[[2021,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkab226","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,7,2]]}}}